SWOT analysis of ABBOTT lab.

1. SWOT Analysis
By- Pritam singh
MBA PM-06

2. Founded in 1888 from the kitchen of Chicago
Doctor, Wallace C. Abbott
One of oldest most successful pharmaceutical
companies in the world
The company manufactures a number of
nutritional and pharmaceutical products,
laboratory diagnostics, pharmaceutical
therapies and medical devices

4. Global Presence
Innovation Leader in Industry
 Duphalac enema
 Tutaferon
Over 100 Years Success And Experience
Environmental Management & Image
 Reduce CO2 emission by 15%
 Reduce water intake by 50%

5. Diverse Product Line
 Specialized medicine and nutri supplements for
infants, children and adults
Nutritional Products
 E.g.- similac, pediasure, ensure and nutripals
 Contributes approx. 16% of its annual sales

6. Upcoming Expiring Patent
 bioxin- 33%loss in sale
 depakote
High Research Costs
 Inaugurated 2 R&D facilities in China and
Singapore
 Invested $3.7billion
Recent Company Layoffs
 6% of its workforce laid off in last two years

7. Declining Market Share
 EU pricing pressure
 Intensifying generic competition
Limited Investor Confidence
 Fall in growth rate during 2011-12
 21% to 10.9%
Product Callbacks
 Similac powder in plastic container
 Refused by US FDA

8. Product Innovation
 Ensure- a meal replacement shake
 Treat obesity by suppressing appetite
shift from acute to chronic
 Heart disease, stroke, diabetes etc
Rural market
 3% increase in sale over a 3 year period 2010-
13
 Empowered patient

9. Government policies
 DPCO 2013 affected Thyronorm, Obimet,
Epilex
Aggressive Competition From Generics
 Depakote faced generic competition
 Prices up to 80%less than brand name
Litigation cases
 against Ranbaxy Laboratories
 22.5million’s Tricor lawsuit on royalty issue

10. Abbott India Financial
report 2013
 Company outperform
the Indian pharma
market with 14.1%
growth where the market
grew by 10.1%
Duphaston,Udiliv and
Duphalac–together
generate more than 250
Crores in revenue.
2500
2000
1500
1000
500
0
Total revenue in cr.
1510
1675
2345
revenue in cr

11. http://en.wikipedia.org/wiki/Abbott_Laboratories
http://www.lawyersandsettlements.com/articles/depakote/de
pakote-lawsuit-side-effects
http://www.biojobblog.com/
http://www.drugpatentwatch.com/
http://www.worldpharmanews.com/abbott/874-abbott-to-acquire-
nutrition-businesses-expanding-presence-in-india>
http://abbottnutrition.com/about-us/about-abbott-nutrition>
http://www.drugs.com/manufacturer/abbott-laboratories-
2.html>